{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:26:51Z","timestamp":1782307611809,"version":"3.54.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Creativity, the capacity and motivation to produce novel and personally meaningful ideas or behaviors, can be influenced by Parkinson\u2019s disease (PD). Non-motor neuropsychological symptoms, such as apathy and negative schizotypy have been linked to reduced creativity, while dopaminergic treatments are associated with increased creative engagement. Building on epidemiological findings investigating changes in creativity, we examined possible drivers of increased and decreased creative activity. In a cross-sectional study, 360 participants with PD completed a questionnaire assessing self-reported creativity changes and associated factors, including personality (Big-Five, Multidimensional-Schizotypy-Scale), lifestyle (e.g., creative lifestyle, free time), and clinical (HY-scores, MoCA, dopaminergic treatments). Using machine learning (gradient-boosted decision-trees), we explained 23% of variance in creativity changes. Dopamine agonists, extraversion, free time, and a creative lifestyle since symptom onset predicted increased creativity, while disorganized schizotypy predicted decreases. The findings provide new insights for future research on creativity as part of PD\u2019s neuropsychological spectrum and for person-centered treatment.<\/jats:p>","DOI":"10.1038\/s41531-025-01165-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:56:03Z","timestamp":1763556963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuropsychological insights into creativity in people with Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Sara","family":"Zeggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Steyrl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Pelowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Krack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirwan K. L.","family":"Darweesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Crone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan J.","family":"Meinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca T. M.","family":"Spee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"1165_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz, J. D. et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 344\u2013381 (2024).","journal-title":"Lancet Neurol."},{"key":"1165_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1165_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"AA Kehagia","year":"2010","unstructured":"Kehagia, A. A., Barker, R. A. & Robbins, T. W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol. 9, 1200\u20131213 (2010).","journal-title":"Lancet Neurol."},{"key":"1165_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/JPD-150698","volume":"6","author":"VMJ Lamberti","year":"2016","unstructured":"Lamberti, V. M. J. et al. Profile of neuropsychiatric symptoms in Parkinson\u2019s disease: surgical candidates compared to controls. J. Parkinson\u2019s Dis. 6, 133\u2013142 (2016).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1165_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/09593543241290232","volume":"35","author":"A Abraham","year":"2025","unstructured":"Abraham, A. Why the standard definition of creativity fails to capture the creative act. Theory Psychol. 35, 40\u201360 (2025).","journal-title":"Theory Psychol."},{"key":"1165_CR6","doi-asserted-by":"crossref","unstructured":"Dietrich, A. Types of creativity. Psychonom. Bull. Rev. 26, 1\u201312 (2019).","DOI":"10.3758\/s13423-018-1517-7"},{"key":"1165_CR7","doi-asserted-by":"crossref","unstructured":"Jung, R. E. & Vartanian, O. The Cambridge Handbook of the Neuroscience of Creativity (Cambridge University Press, 2018).","DOI":"10.1017\/9781316556238"},{"key":"1165_CR8","unstructured":"Sternberg, R. J. Handbook of Creativity (Cambridge University Press, 1999)."},{"key":"1165_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41531-025-00924-1","volume":"11","author":"BTM Spee","year":"2025","unstructured":"Spee, B. T. M. et al. Prevalence of experienced changes in artistic and everyday creativity in people with Parkinson\u2019s disease. npj Parkinsons Dis. 11, 97 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1165_CR10","doi-asserted-by":"publisher","first-page":"930293","DOI":"10.3389\/fpsyg.2022.930293","volume":"13","author":"BTM Spee","year":"2022","unstructured":"Spee, B. T. M. et al. Repeating patterns: Predictive processing suggests an aesthetic learning role of the basal ganglia in repetitive stereotyped behaviors. Front. Psychol. 13, 930293 (2022).","journal-title":"Front. Psychol."},{"key":"1165_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnagi.2014.00164","volume":"6","author":"V Fleury","year":"2014","unstructured":"Fleury, V. et al. Dopaminergic modulation of emotional conflict in Parkinson\u2019s disease. Front. Aging Neurosci. 6, 164 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"1165_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/mds.27065","volume":"32","author":"E Lhomm\u00e9e","year":"2017","unstructured":"Lhomm\u00e9e, E. et al. Personality, dopamine, and Parkinson\u2019s disease: insights from subthalamic stimulation. Mov. Disord. 32, 1191\u20131200 (2017).","journal-title":"Mov. Disord."},{"key":"1165_CR13","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/ene.13752","volume":"25","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh, S. K. L. et al. Professional occupation and the risk of Parkinson\u2019s disease. Eur. J. Neurol. 25, 1470\u20131476 (2018).","journal-title":"Eur. J. Neurol."},{"key":"1165_CR14","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s00415-015-7828-y","volume":"262","author":"CA Haaxma","year":"2015","unstructured":"Haaxma, C. A., Borm, G. F., van der Linden, D., Kappelle, A. C. & Bloem, B. R. Artistic occupations are associated with a reduced risk of Parkinson\u2019s disease. J. Neurol. 262, 2171\u20132176 (2015).","journal-title":"J. Neurol."},{"key":"1165_CR15","doi-asserted-by":"crossref","unstructured":"Lauring, J. O. et al. Why would Parkinson\u2019s disease lead to sudden changes in creativity, motivation, or style with visual art?: a review of case evidence and new neurobiological, contextual, and genetic hypotheses, Neuroscience and Biobehavioral Reviews, pp. 129-165 (Elsevier, 2019).","DOI":"10.1016\/j.neubiorev.2018.12.016"},{"key":"1165_CR16","doi-asserted-by":"publisher","first-page":"103597","DOI":"10.1016\/j.bandc.2019.103597","volume":"136","author":"JO Lauring","year":"2019","unstructured":"Lauring, J. O. et al. Parkinson\u2019s disease and changes in the appreciation of art: A comparison of aesthetic and formal evaluations of paintings between PD patients and healthy controls. Brain Cogn. 136, 103597 (2019).","journal-title":"Brain Cogn."},{"key":"1165_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.plrev.2022.07.005","volume":"43","author":"M Pelowski","year":"2022","unstructured":"Pelowski, M. et al. Can we really \u2018read\u2019 art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease. Phys. Life Rev. 43, 32\u201395 (2022).","journal-title":"Phys. Life Rev."},{"key":"1165_CR18","doi-asserted-by":"crossref","unstructured":"Bloem, B. R., Pfeijffer, I. L. & Krack, P. Art for better health and wellbeing. BMJ Brit. Med. J. 363, 5353 (2018).","DOI":"10.1136\/bmj.k5353"},{"key":"1165_CR19","first-page":"55","volume":"5","author":"E Lhomm\u00e9e","year":"2014","unstructured":"Lhomm\u00e9e, E. et al. Dopamine and the biology of creativity: lessons from Parkinson\u2019s disease. Front. Neurol. 5, 55 (2014).","journal-title":"Front. Neurol."},{"key":"1165_CR20","doi-asserted-by":"crossref","unstructured":"Maradan-Gachet, M. E., Debove, I., Lhomm\u00e9e, E. & Krack, P. Creativity and Parkinson\u2019s Disease, in: A. Richard, M. Pelowski, B. T. M. Spee (Eds.), Art and Neurological Disorders: Illuminating the Intersection of Creativity and the Changing Brain, pp. 65-89 (Springer International Publishing, 2023).","DOI":"10.1007\/978-3-031-14724-1_3"},{"key":"1165_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neubiorev.2017.04.007","volume":"78","author":"N Boot","year":"2017","unstructured":"Boot, N., Baas, M., van Gaal, S., Cools, R. & De Dreu, C. K. W. Creative cognition and dopaminergic modulation of fronto-striatal networks: integrative review and research agenda. Neurosci. Biobehav. Rev. 78, 13\u201323 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1165_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.neurol.2018.07.005","volume":"174","author":"M B\u00e9reau","year":"2018","unstructured":"B\u00e9reau, M. et al. Hyperdopaminergic behavioral spectrum in Parkinson\u2019s disease: a review. Rev. Neurologique 174, 653\u2013663 (2018).","journal-title":"Rev. Neurologique"},{"key":"1165_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1511\/2020.108.4.240","volume":"108","author":"M Pelowski","year":"2020","unstructured":"Pelowski, M., Spee, B. T. M., Richard, A., Krack, P. & Bloem, B. R. What Parkinson\u2019s reveals about the artistic spark. Am. Sci. 108, 240\u2013244 (2020).","journal-title":"Am. Sci."},{"key":"1165_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.plrev.2023.03.002","volume":"45","author":"BR Bloem","year":"2023","unstructured":"Bloem, B. R. & Volpe, D. What art can tell us about the human brain, in health and disease: comment on \u201cCan we really \u2018read\u2019 art to see the changing brain\u201d. Phys. Life Rev. 45, 52\u201355 (2023).","journal-title":"Phys. Life Rev."},{"key":"1165_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1176\/jnp.2.3.282","volume":"2","author":"MA Menza","year":"1990","unstructured":"Menza, M. A., Forman, N. E., Goldstein, H. S. & Golbe, L. I. Parkinson\u2019s disease, personality, and dopamine. J. Neuropsychiatry Clin. Neurosci. 2, 282\u2013287 (1990).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"1165_CR26","doi-asserted-by":"publisher","first-page":"13272","DOI":"10.1073\/pnas.231313198","volume":"98","author":"V Kaasinen","year":"2001","unstructured":"Kaasinen, V. et al. Personality traits and brain dopaminergic function in Parkinson\u2019s disease. Proc. Natl Acad. Sci. 98, 13272\u201313277 (2001).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1165_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.parkreldis.2017.01.017","volume":"37","author":"F Baig","year":"2017","unstructured":"Baig, F. et al. Personality and addictive behaviours in early Parkinson\u2019s disease and REM sleep behaviour disorder. Parkinsonism Relat. Disord. 37, 72\u201378 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1165_CR28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/mds.28575","volume":"36","author":"A Terracciano","year":"2021","unstructured":"Terracciano, A. et al. Neuroticism and risk of Parkinson\u2019s disease: a meta-analysis. Mov. Disord. 36, 1863\u20131870 (2021).","journal-title":"Mov. Disord."},{"key":"1165_CR29","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JPD-202522","volume":"11","author":"J Sieurin","year":"2021","unstructured":"Sieurin, J., Zhan, Y., Pedersen, N. L. & Wirdefeldt, K. Neuroticism, smoking, and the risk of Parkinson\u2019s disease. J. Parkinson\u2019s Dis. 11, 1325\u20131334 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1165_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/brain\/awq032","volume":"133","author":"S Thobois","year":"2010","unstructured":"Thobois, S., Ardouin, C., Lhomm\u00e9e, E. & Krack, P. Non-motor dopamine withdrawal syndrome after surgery for Parkinson\u2019s disease: predictors and underlying mesolimbic denervation. Brain 133, 1111\u20131127 (2010).","journal-title":"Brain"},{"key":"1165_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80765-5","volume":"11","author":"CR Oehrn","year":"2021","unstructured":"Oehrn, C. R. et al. Schizotypy in Parkinson\u2019s disease predicts dopamine-associated psychosis. Sci. Rep. 11, 1\u201310 (2021).","journal-title":"Sci. Rep."},{"key":"1165_CR32","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.24181","volume":"75","author":"A Faust-Socher","year":"2014","unstructured":"Faust-Socher, A., Kenett, Y. N., Cohen, O. S., Hassin-Baer, S. & Inzelberg, R. Enhanced creative thinking under dopaminergic therapy in Parkinson disease. Ann. Neurol. 75, 935\u2013942 (2014).","journal-title":"Ann. Neurol."},{"key":"1165_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000088645","volume":"54","author":"J Bogousslavsky","year":"2005","unstructured":"Bogousslavsky, J. Artistic creativity, style and brain disorders. Eur. Neurol. 54, 103\u2013111 (2005).","journal-title":"Eur. Neurol."},{"key":"1165_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-444-63364-4.00021-1","volume":"206","author":"J Bogousslavsky","year":"2013","unstructured":"Bogousslavsky, J. & Paciaroni, M. Parkinsonism in Poets and Writers. Prog. Brain Res. 206, 59\u201371 (2013).","journal-title":"Prog. Brain Res."},{"key":"1165_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1037\/aca0000378","volume":"16","author":"CA Stamatis","year":"2022","unstructured":"Stamatis, C. A. & Weisman de Mamani, A. A latent profile analysis of creativity: associations of convergent and divergent thinking with subclinical schizotypal, obsessive-compulsive, and affective symptoms. Psychol. Aesthet. Creativity, Arts 16, 651\u2013664 (2022).","journal-title":"Psychol. Aesthet. Creativity, Arts"},{"key":"1165_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/00332747.1989.11024436","volume":"52","author":"KR Jamison","year":"1989","unstructured":"Jamison, K. R. Mood disorders and patterns of creativity in British writers and artists. Psychiatry 52, 125\u2013134 (1989).","journal-title":"Psychiatry"},{"key":"1165_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S2215-0366(17)30013-5","volume":"4","author":"D Mohammadi","year":"2017","unstructured":"Mohammadi, D. Nancy C Andreasen: creativity and mental illness. Lancet Psychiatry 4, 192 (2017).","journal-title":"Lancet Psychiatry"},{"key":"1165_CR38","doi-asserted-by":"crossref","unstructured":"Jamison, K. R. Touched with fire: Manic-depressive illness and the artistic temperament (Simon and Schuster, 1996).","DOI":"10.1007\/978-1-4899-0170-5_6"},{"key":"1165_CR39","doi-asserted-by":"crossref","unstructured":"Eysenck, H. J. Creativity as a product of intelligence and personality, International handbook of personality and intelligence pp. 231-247 (Springer, 1995).","DOI":"10.1007\/978-1-4757-5571-8_12"},{"key":"1165_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-022-00283-1","volume":"8","author":"A Alonso-Canovas","year":"2022","unstructured":"Alonso-Canovas, A. et al. The silver linings of Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 8, 21\u201321 (2022).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"1165_CR41","doi-asserted-by":"crossref","unstructured":"Stap, T. B. et al. Holding Still, Together: Person-Centered Parkinson\u2019s Care Portrayed, in: A. Richard, M. Pelowski, B. T. M. Spee (Eds.), art and neurological disorders: illuminating the intersection of creativity and the changing brain pp. 197-214 (Springer International Publishing, 2023).","DOI":"10.1007\/978-3-031-14724-1_8"},{"key":"1165_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JPD-240031","volume":"24","author":"P Gros","year":"2024","unstructured":"Gros, P., Spee, B. T. M., Bloem, B. R. & Kalia, L. V. If art were a drug: implications for Parkinson\u2019s disease. J. Parkinson\u2019s Dis. 24, 159\u2013172 (2024).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1165_CR43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12883-021-02308-3","volume":"21","author":"JHL Ypinga","year":"2021","unstructured":"Ypinga, J. H. L. et al. Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL). BMC Neurol. 21, 286\u2013286 (2021).","journal-title":"BMC Neurol."},{"key":"1165_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jrp.2006.02.001","volume":"41","author":"B Rammstedt","year":"2007","unstructured":"Rammstedt, B. & John, O. P. Measuring personality in one minute or less: a 10-item short version of the big five inventory in english and german. J. Res. Personal. 41, 203\u2013212 (2007).","journal-title":"J. Res. Personal."},{"key":"1165_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.psychres.2017.12.033","volume":"261","author":"GM Gross","year":"2018","unstructured":"Gross, G. M., Kwapil, T. R., Raulin, M. L., Silvia, P. J. & Barrantes-Vidal, N. The multidimensional schizotypy scale-brief: Scale development and psychometric properties. Psychiatry Res. 261, 7\u201313 (2018).","journal-title":"Psychiatry Res."},{"key":"1165_CR46","doi-asserted-by":"publisher","first-page":"e0237614","DOI":"10.1371\/journal.pone.0237614","volume":"15","author":"KC Kemp","year":"2020","unstructured":"Kemp, K. C., Bathery, A. J., Barrantes-Vidal, N. & Kwapil, T. R. A brief questionnaire measure of multidimensional schizotypy predicts interview-rated symptoms and impairment. PLOS ONE 15, e0237614\u2013e0237614 (2020).","journal-title":"PLOS ONE"},{"key":"1165_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.schres.2017.07.001","volume":"193","author":"TR Kwapil","year":"2018","unstructured":"Kwapil, T. R., Gross, G. M., Silvia, P. J., Raulin, M. L. & Barrantes-Vidal, N. Development and psychometric properties of the Multidimensional Schizotypy Scale: A new measure for assessing positive, negative, and disorganized schizotypy. Schizophrenia Res. 193, 209\u2013217 (2018).","journal-title":"Schizophrenia Res."},{"key":"1165_CR48","doi-asserted-by":"crossref","unstructured":"Eysenck, H. J. Genius: A Natural History of Creativity (Cambridge University Press, 1995).","DOI":"10.1017\/CBO9780511752247"},{"key":"1165_CR49","doi-asserted-by":"crossref","unstructured":"Furnham, A. Personality and Creativity, O Perceptual and Motor Skills, pp. 407-408 (Sage, 1999).","DOI":"10.2466\/pms.1999.88.2.407"},{"key":"1165_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpsychires.2022.07.009","volume":"153","author":"TA Greenwood","year":"2022","unstructured":"Greenwood, T. A., Chow, L. J., Gur, R. C. & Kelsoe, J. R. Bipolar spectrum traits and the space between madness and genius: the muse is in the dose. J. Psychiatr. Res. 153, 149\u2013158 (2022).","journal-title":"J. Psychiatr. Res."},{"key":"1165_CR51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","volume":"165","author":"C Ardouin","year":"2009","unstructured":"Ardouin, C. et al. \u00c9valuation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson. Rev. Neurologique 165, 845\u2013856 (2009).","journal-title":"Rev. Neurologique"},{"key":"1165_CR52","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jrp.2005.09.004","volume":"40","author":"D Nettle","year":"2006","unstructured":"Nettle, D. Schizotypy and mental health amongst poets, visual artists, and mathematicians. J. Res. Personal. 40, 876\u2013890 (2006).","journal-title":"J. Res. Personal."},{"key":"1165_CR53","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.tics.2023.04.004","volume":"27","author":"RE Beaty","year":"2023","unstructured":"Beaty, R. E. & Kenett, Y. N. Associative thinking at the core of creativity. Trends Cogn. Sci. 27, 671\u2013683 (2023).","journal-title":"Trends Cogn. Sci."},{"key":"1165_CR54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1037\/a0039303","volume":"9","author":"B Polner","year":"2015","unstructured":"Polner, B., Nagy, H., Tak\u00e1ts, A. & K\u00e9ri, S. Kiss of the muse for the chosen ones: de novo schizotypal traits and lifetime creative achievement are related to changes in divergent thinking during dopaminergic therapy in Parkinson\u2019s disease. Psychol. Aesthet., Creativity, Arts 9, 328\u2013339 (2015).","journal-title":"Psychol. Aesthet., Creativity, Arts"},{"key":"1165_CR55","doi-asserted-by":"crossref","unstructured":"Beaty, R. E., Benedek, M., Silvia, P. J. & Schacter, D. L. Creative Cognition and Brain Network Dynamics, Trends in Cognitive Sciences, pp. 87-95 (Elsevier, 2016).","DOI":"10.1016\/j.tics.2015.10.004"},{"key":"1165_CR56","doi-asserted-by":"crossref","unstructured":"Baer, J. Creativity and Divergent Thinking (Psychology Press, 2014).","DOI":"10.4324\/9781315806785"},{"key":"1165_CR57","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1038\/s41598-023-39865-1","volume":"13","author":"BTM Spee","year":"2023","unstructured":"Spee, B. T. M. et al. Machine learning revealed symbolism, emotionality, and imaginativeness as primary predictors of creativity evaluations of western art paintings. Sci. Rep. 13, 12966 (2023).","journal-title":"Sci. Rep."},{"key":"1165_CR58","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/bs.pbr.2022.01.012","volume":"269","author":"R Cools","year":"2022","unstructured":"Cools, R. et al. Smulders, M.H.M. Timmer, Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson\u2019s disease. Prog. Brain Res. 269, 309\u2013343 (2022).","journal-title":"Prog. Brain Res."},{"key":"1165_CR59","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/brain\/awad162","volume":"146","author":"JG Tichelaar","year":"2023","unstructured":"Tichelaar, J. G., Sayal\u0131, C., Helmich, R. C. & Cools, R. Impulse control disorder in Parkinson\u2019s disease is associated with abnormal frontal value signalling. Brain 146, 3676\u20133689 (2023).","journal-title":"Brain"},{"key":"1165_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neurol.2024.11.004","volume":"181","author":"D Amstutz","year":"2024","unstructured":"Amstutz, D. et al. Psychiatric and cognitive symptoms of Parkinson\u2019s disease: A life\u2019s tale. Rev. Neurologique 181, 265\u2013283 (2024).","journal-title":"Rev. Neurologique"},{"key":"1165_CR61","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00415-024-12878-0","volume":"272","author":"BTM Spee","year":"2025","unstructured":"Spee, B. T. M. et al. Unleashing creativity in people with Parkinson\u2019s disease: a pilot study of a co-designed creative arts therapy. J. Neurol. 272, 161 (2025).","journal-title":"J. Neurol."},{"key":"1165_CR62","doi-asserted-by":"crossref","unstructured":"Spee, B. T. M. et al. Co-creating a person-centered creative engagement intervention for Parkinson\u2019s care. Front. Psychol. 15, 1469120 (2025).","DOI":"10.3389\/fpsyg.2024.1469120"},{"key":"1165_CR63","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mds.26223","volume":"30","author":"I Rieu","year":"2015","unstructured":"Rieu, I. et al. International validation of a behavioral scale in Parkinson\u2019s disease without dementia. Mov. Disord. 30, 705\u2013713 (2015).","journal-title":"Mov. Disord."},{"key":"1165_CR64","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.27689","volume":"34","author":"AH Evans","year":"2019","unstructured":"Evans, A. H. et al. Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: critique and recommendations. Mov. Disord. 34, 791\u2013798 (2019).","journal-title":"Mov. Disord."},{"key":"1165_CR65","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3233\/JPD-150535","volume":"5","author":"M Sierra","year":"2015","unstructured":"Sierra, M. et al. Apathy and impulse control disorders: yin & yang of dopamine dependent behaviors. J. Parkinson\u2019s Dis. 5, 625\u2013636 (2015).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1165_CR66","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/070674371105600304","volume":"56","author":"SH Carson","year":"2011","unstructured":"Carson, S. H. Creativity and psychopathology: a shared vulnerability model. Can. J. Psychiatry 56, 144\u2013153 (2011).","journal-title":"Can. J. Psychiatry"},{"key":"1165_CR67","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/brain\/awp094","volume":"132","author":"N B\u00f3di","year":"2009","unstructured":"B\u00f3di, N. et al. Reward-learning and the novelty-seeking personality: a between-and within-subjects study of the effects of dopamine agonists on young Parkinson\u2019s patients. Brain 132, 2385\u20132395 (2009).","journal-title":"Brain"},{"key":"1165_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","volume":"30","author":"R Cools","year":"2006","unstructured":"Cools, R. Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson\u2019s disease. Neurosci. Biobehav. Rev. 30, 1\u201323 (2006).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1165_CR69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mds.29700","volume":"39","author":"I Debove","year":"2024","unstructured":"Debove, I. et al. Management of impulse control and related disorders in Parkinson\u2019s disease: an expert consensus. Mov. Disord. 39, 235\u2013248 (2024).","journal-title":"Mov. Disord."},{"key":"1165_CR70","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.26164","volume":"90","author":"D Weiss","year":"2021","unstructured":"Weiss, D. et al. Changing gears - DBS for dopaminergic desensitization in Parkinson\u2019s disease? Ann. Neurol. 90, 699\u2013710 (2021).","journal-title":"Ann. Neurol."},{"key":"1165_CR71","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/mds.27101","volume":"32","author":"B Delpont","year":"2017","unstructured":"Delpont, B. et al. Psychostimulant effect of dopaminergic treatment and addictions in Parkinson\u2019s disease. Mov. Disord. 32, 1566\u20131573 (2017).","journal-title":"Mov. Disord."},{"key":"1165_CR72","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","volume":"133","author":"D Weintraub","year":"2017","unstructured":"Weintraub, D. & Claassen, D. O. Impulse control and related disorders in Parkinson\u2019s disease. Int. Rev. Neurobiol. 133, 679\u2013717 (2017).","journal-title":"Int. Rev. Neurobiol."},{"key":"1165_CR73","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1037\/a0023795","volume":"125","author":"DO Claassen","year":"2011","unstructured":"Claassen, D. O. et al. The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav. Neurosci. 125, 492 (2011).","journal-title":"Behav. Neurosci."},{"key":"1165_CR74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1474-4422(20)30064-8","volume":"19","author":"BR Bloem","year":"2020","unstructured":"Bloem, B. R. et al. Integrated and patient-centred management of Parkinson\u2019s disease: a network model for reshaping chronic neurological care. Lancet Neurol. 19, 623\u2013634 (2020).","journal-title":"Lancet Neurol."},{"key":"1165_CR75","unstructured":"Leiner, D. J. SoSci Survey (Version 3.2.43) [Computer Software], http:\/\/www.soscisurvey.com, 2018."},{"key":"1165_CR76","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/jocb.396","volume":"54","author":"M Benedek","year":"2020","unstructured":"Benedek, M., Bruckdorfer, R. & Jauk, E. Motives for creativity: exploring the what and why of everyday creativity. J. Creative Behav. 54, 610\u2013625 (2020).","journal-title":"J. Creative Behav."},{"key":"1165_CR77","doi-asserted-by":"crossref","unstructured":"Cousins, E.,Tischler, V., Garabedian, C. & Dening, T. A Taxonomy of arts interventions for people with dementia. Gerontologist 60, 124\u2013134 (2019).","DOI":"10.1093\/geront\/gnz024"},{"key":"1165_CR78","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-2753.2010.01434.x","volume":"17","author":"VD Sousa","year":"2011","unstructured":"Sousa, V. D. & Rojjanasrirat, W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J. Evaluation Clin. Pract. 17, 268\u2013274 (2011).","journal-title":"J. Evaluation Clin. Pract."},{"key":"1165_CR79","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","volume":"25","author":"DE Beaton","year":"2000","unstructured":"Beaton, D. E., Bombardier, C., Guillemin, F. & Ferraz, M. B. Guidelines for the process of cross-cultural adaptation of self-report measure. Spine 25, 3186\u20133191 (2000).","journal-title":"Spine"},{"key":"1165_CR80","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1165_CR81","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatrics Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatrics Soc."},{"key":"1165_CR82","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s43856-022-00180-x","volume":"2","author":"W Qiu","year":"2022","unstructured":"Qiu, W. et al. Interpretable machine learning prediction of all-cause mortality. Commun. Med. 2, 125 (2022).","journal-title":"Commun. Med."},{"key":"1165_CR83","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-clinpsy-032816-045037","volume":"14","author":"DB Dwyer","year":"2018","unstructured":"Dwyer, D. B., Falkai, P. & Koutsouleris, N. Machine learning approaches for clinical psychology and psychiatry. Annu. Rev. Clin. Psychol. 14, 91\u2013118 (2018).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"1165_CR84","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Duchesnay, scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"1165_CR85","first-page":"3146","volume":"30","author":"G Ke","year":"2017","unstructured":"Ke, G. et al. Lightgbm: A highly efficient gradient boosting decision tree. Adv. neural Inf. Process. Syst., Adv. neural Inf. Process. Syst. 30, 3146\u20133154 (2017).","journal-title":"Adv. neural Inf. Process. Syst., Adv. neural Inf. Process. Syst."},{"key":"1165_CR86","first-page":"507","volume":"35","author":"L Grinsztajn","year":"2022","unstructured":"Grinsztajn, L., Oyallon, E. & Varoquaux, G. Adv. Neural Inf. Process. Syst. 35, 507\u2013520 (2022).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"1165_CR87","first-page":"2079","volume":"11","author":"GC Cawley","year":"2010","unstructured":"Cawley, G. C. & Talbot, N. L. C. On over-fitting in model selection and subsequent selection bias in performance evaluation. J. Mach. Learn. Res. 11, 2079\u20132107 (2010).","journal-title":"J. Mach. Learn. Res."},{"key":"1165_CR88","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41593-022-01110-9","volume":"25","author":"MD Rosenberg","year":"2022","unstructured":"Rosenberg, M. D. & Finn, E. S. How to establish robust brain\u2013behavior relationships without thousands of individuals. Nat. Neurosci. 25, 835\u2013837 (2022).","journal-title":"Nat. Neurosci."},{"key":"1165_CR89","unstructured":"Hastie, T. Tibshirani, R. & Friedman, J. The Elements of Statistical Learning Data Mining, Inference, and Prediction, 2nd ed. (Springer, 2016)."},{"key":"1165_CR90","first-page":"4765","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst., Adv. Neural Inf. Process. Syst. 30, 4765\u20134774 (2017).","journal-title":"Adv. Neural Inf. Process. Syst., Adv. Neural Inf. Process. Syst."},{"key":"1165_CR91","unstructured":"Molnar, C. Interpretable machine learning. A Guide for Making Black Box Models Explainable, https:\/\/christophm.github.io\/interpretable-ml-book\/, (2019)."},{"key":"1165_CR92","doi-asserted-by":"crossref","unstructured":"Bouckaert, R. R. & Frank, E. Evaluating the Replicability of Significance Tests for Comparing Learning Algorithms, pp. 3-12 (Springer, 2004).","DOI":"10.1007\/978-3-540-24775-3_3"},{"key":"1165_CR93","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1024068626366","volume":"52","author":"C Nadeau","year":"2003","unstructured":"Nadeau, C. Inference for the generalization error. Mach. Learn., Mach. Learn. 52, 239\u2013281 (2003).","journal-title":"Mach. Learn., Mach. Learn."},{"key":"1165_CR94","doi-asserted-by":"crossref","unstructured":"Rosenbusch, H., Soldner, F., Evans, A. M. & Zeelenberg, M. Supervised machine learning methods in psychology: a practical introduction with annotated R code. Soc. Pers. Psychol. Compass 15, e12579 (2021).","DOI":"10.1111\/spc3.12579"},{"key":"1165_CR95","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley, R. D. et al. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat. Med. 38, 1276\u20131296 (2019).","journal-title":"Stat. Med."},{"key":"1165_CR96","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff, E. & McCulloch, C. E. Relaxing the rule of ten events per variable in logistic and cox regression. Am. J. Epidemiol. 165, 710\u2013718 (2007).","journal-title":"Am. J. Epidemiol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01165-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:04:10Z","timestamp":1763561050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01165-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01165-y","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Bloem serves as the co-Editor in Chief for the Journal of PD, serves on the editorial board of Practical Neurology and Digital Biomarkers, has received fees from serving on the scientific advisory board for the Critical Path Institute, Gyenno Science, MedRhythms, UCB, Kyowa Kirin and Zambon (paid to the Institute), has received fees for speaking at conferences from AbbVie, Bial, Biogen, GE Healthcare, Oruen, Roche, UCB and Zambon (paid to the Institute), and has received research support from Biogen, Cure Parkinson\u2019s, Davis Phinney Foundation, Edmond J. Safra Foundation, Fred Foundation, Gatsby Foundation, Hersenstichting Nederland, Horizon 2020, IRLAB Therapeutics, Maag Lever Darm Stichting, Michael J Fox Foundation, Ministry of Agriculture, Ministry of Economic Affairs & Climate Policy, Ministry of Health, Welfare and Sport, Netherlands Organization for Scientific Research (ZonMw), Not Impossible, Parkinson Vereniging, Parkinson\u2019s Foundation, Parkinson\u2019s UK, Stichting Alkemade-Keuls, Stichting Parkinson NL, Stichting Woelse Waard, Topsector Life Sciences and Health, UCB, Verily Life Sciences, Roche and Zambon. Prof. Bloem does not hold any stocks or stock options with any companies that are connected to PD or to any of his clinical or research activities. BTM.S. is funded as postdoc by the Austrian Science Fund (FWF \u2013 Der Wissenschaftsfonds), #ConnectingMinds under grant agreement number CM 1100-B with the short title: Unlocking the Muse. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}